The business, a direct-to-consumer eye-health supplement brand, launched on Shopify in August 2026, is seeing strong growth with US$8,488.21 in active subscription revenue at a 77% gross margin, equating to approximately US$6,500 in gross profit from subscribed customers. In its initial 14 weeks, the business achieved US$69,620 in gross revenue through 1,134 orders, with a repeat customer rate of 19%. The major market is Australia, accounting for 84% of orders, though the brand has tested international markets such as the US, Canada, the UK, New Zealand, and Europe. The product, a 15-in-1 daily eye-health capsule, is manufactured in a GMP-certified facility and packaged under a white-label formula. The stock is stored in China and shipped globally, minimizing the need for warehousing or physical stock management. The operational workload is light, requiring about four hours per week, focusing on ad management, order processing, and overseeing outsourced customer support. The target demographic is primarily adults over 50 years old, with acquisition primarily driven through Meta ads. Despite the limited product range currently tested, additional products are ready to launch. The business, built from scratch in 2026, achieved US$24,000 in monthly revenue by its second month. It is included for sale with all assets and support, as the current owner shifts focus to another venture. The sale includes the Shopify store, all digital assets, and stock, with the owner providing 30 days of support for transitional operations.